We're a team of more than 6,500 people united by a single purpose: to help eradicate cancer by preventing it, detecting it earlier, and guiding personalized treatment. Founded in 1995, we've grown from a small startup in Marlborough, Massachusetts to a leading molecular diagnostics company headquartered in Madison, Wisconsin. Our flagship product, Cologuard, revolutionized colorectal cancer screening by offering a non-invasive at-home test that detects cancer and precancer.
Today, our portfolio spans across the cancer continuum - from prevention and screening to treatment guidance and monitoring. We serve patients and healthcare providers in more than 120 countries, and in 2023 alone, we helped more than 4 million people get answers about their cancer risk. What drives us isn't just the science - it's the people behind every test. We've been certified as a Great Place To Work for seven years running because we believe that changing lives starts with supporting our team.